Colorado made roughly $2 million in marijuana taxes in January, state revenue officials reported Monday.» Read More
Onyx Pharmaceuticals has rejected a $10 billion takeover bid from Amgen, reports CNBC's Bertha Coombs.
Onyx Pharmaceuticals Inc on Sunday confirmed it had rejected an offer from Amgen Inc.
The Obama administration is reaching out to the NFL, the NBA and Hollywood celebrities to help promote enrollment in the new programs created under Obamacare. Ron Pollack, Families USA; Guy Benson, TownHall.com; and Carly Fiorina, Former Hewlett-Packard CEO, discuss.
The Supreme Court’s ruling on gay marriage isn’t just an emotional victory for same-sex spouses. It’s a practical one that will usher in a sea change and prompt lawsuits.
Young adults make up a disproportionate share of the nation's 50 million uninsured. Getting them to sign up for insurance coverage will be a major focus of the government this fall during the roll-out of Obamacare.
Larry Robbins, Glenview Capital Management founder and CEO, explains why he's taking a "suggestion" directly to shareholders of Health Management Associates to replace eight board members.
Hedge Fund Glenview Capital wants a shake-up of the board of Health Management Associates, saying the health-care company has underperformed its competitors.
Mounting medical bills are likely to force many people to file for bankruptcy, according to new data from NerdWallet. And even those with insurance are buckling under unpaid bills.
The $1.8 billion deal for Vanguard Health Systems is not the last major acquisition Tenet Healthcare will make, the company's CEO Trevor Fetter told CNBC.
After striking a $1.8 billion deal to purchase Vanguard Health Systems, Tenet's CEO Trevor Fetter said the company will be "more aggressive with acquisitions."
The "Squawk on the Street" team discusses the terms of Tenet's offer, and weigh in on Vodafone's $10 billion buyout offer for Kabel Deutschland.
Top doctors are calling attention to new guidance on screening for prostate cancer—the second-leading cause of cancer deaths for American men.
After the selling frenzy dies down, Cramer expects 3 sectors to emerge and ultimately rescue the bulls.
Independent of the debate on the Federal Reserve and interest rates, FTI Consulting's Barbara Ryan expects pharmaceutical and biotech stocks can continue to do well.
The AMA's new recognition of obesity as a "disease" could put a dent into insurers' bottom lines—at least in the short-term—but boost profits for makers of weight-loss drugs.
The American Medical Association says obesity should be classified as a disease. CNBC's Bertha Coombs reports AMA's Patrice Harris says the hope is for doctors to be more proactive in treating obese patients.
Small business owners are already curtailing hiring because of concerns over the cost of Obamacare, a recent survey found.
With the Dow up more than 2000 points for the year, Jim Cramer thinks now is a good time to single out stocks that haven’t rallied, but soon could.
Already sluggish health-care inflation is projected to slow down even more in 2014 as consumers, employers and the federal government continue looking to cut medical costs, a new report said Tuesday.
Months before Americans buy coverage under Obamacare, it's becoming clear that choices for millions of people will vary depending on where they live. The NYT reports.